Does TILDRAKIZUMAB Cause Infection? 13 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Infection have been filed in association with TILDRAKIZUMAB (ILUMYA). This represents 1.5% of all adverse event reports for TILDRAKIZUMAB.
13
Reports of Infection with TILDRAKIZUMAB
1.5%
of all TILDRAKIZUMAB reports
3
Deaths
6
Hospitalizations
How Dangerous Is Infection From TILDRAKIZUMAB?
Of the 13 reports, 3 (23.1%) resulted in death, 6 (46.2%) required hospitalization.
Is Infection Listed in the Official Label?
Yes, Infection is listed as a known adverse reaction in the official FDA drug label for TILDRAKIZUMAB.
What Other Side Effects Does TILDRAKIZUMAB Cause?
Product dose omission issue (53)
Death (50)
Drug ineffective (50)
Psoriasis (37)
Urinary tract infection (36)
Pneumonia (33)
Off label use (27)
Condition aggravated (25)
Covid-19 (25)
Inappropriate schedule of product administration (22)
What Other Drugs Cause Infection?
ADALIMUMAB (11,552)
METHOTREXATE (10,406)
ETANERCEPT (10,379)
RITUXIMAB (9,575)
ABATACEPT (7,821)
TOCILIZUMAB (7,349)
PREDNISONE (6,334)
TOFACITINIB (6,332)
INFLIXIMAB (6,122)
CERTOLIZUMAB PEGOL (5,954)
Which TILDRAKIZUMAB Alternatives Have Lower Infection Risk?
TILDRAKIZUMAB vs TILDRAKIZUMAB-ASMN
TILDRAKIZUMAB vs TILIDINE
TILDRAKIZUMAB vs TIMOLOL
TILDRAKIZUMAB vs TIMOLOL\TRAVOPROST
TILDRAKIZUMAB vs TINIDAZOLE